NZ336969A - Substituted 4-aminoalkoxy-1H-benzimidazole derivatives useful as dopamine autoreceptor (D2) agonists - Google Patents

Substituted 4-aminoalkoxy-1H-benzimidazole derivatives useful as dopamine autoreceptor (D2) agonists

Info

Publication number
NZ336969A
NZ336969A NZ336969A NZ33696998A NZ336969A NZ 336969 A NZ336969 A NZ 336969A NZ 336969 A NZ336969 A NZ 336969A NZ 33696998 A NZ33696998 A NZ 33696998A NZ 336969 A NZ336969 A NZ 336969A
Authority
NZ
New Zealand
Prior art keywords
alkyl
agonists
substituted
alkoxy
hydrogen
Prior art date
Application number
NZ336969A
Inventor
James Albert Nelson
Richard Eric Mewshaw
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of NZ336969A publication Critical patent/NZ336969A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08—Radicals containing only hydrogen and carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/10—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The substituted benzimidazole-alkoxy-amine derivatives or pharmaceutically acceptable salts thereof have the formula I wherein: R1 is hydrogen, trifluoromethyl, pentafluoroethyl, heptafluoropropyl, alkyl or benzyl optionally substituted by one to three substituents selected from halogen, amino, nitro, hydroxy, alkoxy; R2 is hydrogen or alkyl; R3 is hydrogen, alkyl, cyclohexylmethyl, -(CH2)mAr or phenylbutyl or NR2R3 is 1,2,3,4-tetrahydroquinolin-1-yl or 1,2,3,4-tetrahydroisoquinolin-2-yl; Ar is optionally substituted phenyl, thienyl, furanyl, or pyridinyl, Y is halogen, alkyl, amino or alkoxy and n is 1-5. A pharmaceutical composition thereof is useful for treating diseases that respond to treatment with D2 agonists.
NZ336969A 1997-02-18 1998-01-13 Substituted 4-aminoalkoxy-1H-benzimidazole derivatives useful as dopamine autoreceptor (D2) agonists NZ336969A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80127697A 1997-02-18 1997-02-18
PCT/US1998/000613 WO1998035945A1 (en) 1997-02-18 1998-01-13 4-aminoalkoxy-1h-benzimidazole derivatives, their preparation and their use as dopamine autoreceptor (d2) agonists

Publications (1)

Publication Number Publication Date
NZ336969A true NZ336969A (en) 2001-03-30

Family

ID=25180658

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ336969A NZ336969A (en) 1997-02-18 1998-01-13 Substituted 4-aminoalkoxy-1H-benzimidazole derivatives useful as dopamine autoreceptor (D2) agonists

Country Status (14)

Country Link
EP (1) EP0973749A1 (en)
JP (1) JP2001509814A (en)
KR (1) KR20000071129A (en)
CN (1) CN1252793A (en)
AR (1) AR011136A1 (en)
AU (1) AU746717B2 (en)
BR (1) BR9807701A (en)
CA (1) CA2278700A1 (en)
HU (1) HUP0001302A3 (en)
IL (1) IL131158A0 (en)
NZ (1) NZ336969A (en)
TW (1) TW513415B (en)
WO (1) WO1998035945A1 (en)
ZA (1) ZA981309B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6541502B1 (en) * 2001-07-20 2003-04-01 Wyeth 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity
CN101597262A (en) 2002-03-05 2009-12-09 特兰斯泰克制药公司 The list and the bicyclic pyrrole derivatives that suppress part and advanced glycation end product acceptor interaction
EP2470510B1 (en) 2009-09-30 2014-05-14 TransTech Pharma, LLC Substituted imidazole derivatives for treatment of alzheimers disease.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4704390A (en) * 1986-02-13 1987-11-03 Warner-Lambert Company Phenyl and heterocyclic tetrahydropyridyl alkoxy-benzheterocyclic compounds as antipsychotic agents
PT707007E (en) * 1994-10-14 2002-06-28 Merck Patent Gmbh AMINO DERIVATIVES (TIO) ETER AS ACTIVE AGENTS IN THE CNS
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
CA2264080A1 (en) * 1996-08-27 1998-03-05 Richard Eric Mewshaw 4-aminoethoxy indoles as dopamin d2 agonists and as 5ht1a ligands

Also Published As

Publication number Publication date
HUP0001302A3 (en) 2001-07-30
CN1252793A (en) 2000-05-10
AU746717B2 (en) 2002-05-02
EP0973749A1 (en) 2000-01-26
JP2001509814A (en) 2001-07-24
KR20000071129A (en) 2000-11-25
IL131158A0 (en) 2001-01-28
CA2278700A1 (en) 1998-08-20
WO1998035945A1 (en) 1998-08-20
ZA981309B (en) 1999-08-17
TW513415B (en) 2002-12-11
HUP0001302A2 (en) 2001-05-28
AR011136A1 (en) 2000-08-02
BR9807701A (en) 2000-05-02
AU5915398A (en) 1998-09-08

Similar Documents

Publication Publication Date Title
EP1566379A4 (en) QUINOLINE DERIVATIVES AND QUINAZOLINE DERIVATIVES INHIBITING AUTOPHOSPHORYLATION OF Flt3 AND MEDICINAL COMPOSITIONS CONTAINING THE SAME
ES2196396T3 (en) HETEROAROMATIC COMPOUNDS OF 5 MEMBERS CONTAINING OXYGEN OR SULFUR AS INHIBITORS OF THE XA FACTOR.
FI970148A (en) Use of heterocyclic compounds as dopamine D3 ligands
MXPA05012415A (en) Isoquinoline derivatives and their use as gfat inhibitors.
NO304946B1 (en) Xanthine derivative and its use
ES2174757A1 (en) Utilization of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of proliferative cell diseases
JO2311B1 (en) Alkyne-aryl phosphodiesterase-4 inhibitors
NZ510097A (en) Pyrroloindoles, pyridoindoles and azepinoindoles useful as 5-HT2C agonists
SG128491A1 (en) Heterocyclic sulfonamide inhibitors of beta amyloid production
ES8404990A1 (en) Anti-hypertensive prolinol-based peptides.
MXPA05007115A (en) Novel cb 1 receptor inverse agonists.
TW200503712A (en) (2-carboxamido)(3-amino)thiophene compounds
EP1140900A4 (en) Pyrazole compounds and uses thereof
BR0015195A (en) Compound, pharmaceutical composition, use of a compound, and, methods for treating a condition associated with reduced nicotine transmission for the treatment or prophylaxis of psychotic disorders or disorders of intellectual impairment and for the treatment or prophylaxis of human diseases or conditions
GEP20053626B (en) Substituted 8-Arylquinoline Phosphodiesterase-4 Inhibitors, Pharmaceutical Composition Containing Them and Use Thereof
DE69724098D1 (en) CHINOLINE AND BENZIMIDAZOLE DERIVATIVES AS BRADYKININE AGONISTS
MX9806171A (en) 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors.
AU1367497A (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of prostatic carcinoma
ES2180449A1 (en) Aryl (or heteroaryl) azolylcarbynol derivatives for the treatment of urinary incontinence
HUP0101469A2 (en) 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as alpha-adrenoceptor agonists with improved metabolic stability
NZ336969A (en) Substituted 4-aminoalkoxy-1H-benzimidazole derivatives useful as dopamine autoreceptor (D2) agonists
ATE330958T1 (en) PYRAZINO 1'2':1,6ÖPYRIDO 3,4-BÖINDOL DERIVATIVES
GB0003257D0 (en) Heterocyclic compounds and their therapeutic use
MXPA03000887A (en) Fused heterocyclic derivatives as phosphodiesterase inhibitors.
NZ337271A (en) 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one derivatives and their use as dopamine autoreceptor (D2) agonists

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)